Surgery Partners, Inc. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that Surgery Partners, Inc. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | $460.35M | Mar 16, 2018 |
| FY2017 | Sep 30, 2017 | $132.26M | Mar 16, 2018 |
| FY2016 | Dec 31, 2016 | $306.00M | Mar 10, 2017 |
| FY2016 | Sep 30, 2016 | $282.68M | Mar 10, 2017 |
| FY2016 | Jun 30, 2016 | $289.68M | Mar 10, 2017 |
| FY2016 | Mar 31, 2016 | $267.07M | Mar 10, 2017 |
| FY2016 | Dec 31, 2015 | $263.32M | Mar 10, 2017 |
| FY2016 | Sep 30, 2015 | $239.60M | Mar 10, 2017 |
| FY2016 | Jun 30, 2015 | $232.83M | Mar 10, 2017 |
| FY2016 | Mar 31, 2015 | $224.14M | Mar 10, 2017 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($77.90M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($168.10M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | ($11.90M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | ($54.60M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | ($70.90M) | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | ($116.10M) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | ($19.20M) | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | ($15.70M) | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | ($19.80M) | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | ($20.10M) | Mar 13, 2020 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $389.50M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $348.80M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $328.00M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $345.20M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $302.20M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $183.00M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $235.90M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $77.80M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $92.30M | Mar 13, 2020 |
| FY2019 | Aug 31, 2017 | $66.00M | Mar 13, 2020 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $274.30M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $300.10M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $293.80M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $158.80M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $87.10M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $246.90M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $129.50M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $144.60M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $53.20M | Mar 13, 2020 |
| FY2019 | Aug 31, 2017 | $67.70M | Mar 13, 2020 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $78.70M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $90.40M | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $88.80M | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $80.60M | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $57.60M | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $42.90M | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $73.60M | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $39.80M | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $10.80M | Mar 13, 2020 |
| FY2019 | Aug 31, 2017 | $18.80M | Mar 13, 2020 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $8.12B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $7.89B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $6.88B | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $6.68B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $6.12B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $5.41B | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $5.02B | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $4.68B | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $4.62B | Mar 15, 2019 |
| FY2016 | Dec 31, 2016 | $2.30B | Mar 10, 2017 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.71B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $1.79B | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $1.99B | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $2.00B | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $1.09B | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $115.60M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $296.80M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $404.60M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $654.73M | Mar 15, 2019 |
| FY2016 | Dec 31, 2016 | $9.68M | Mar 10, 2017 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.19B | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $5.07B | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | $4.33B | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | $4.14B | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | $3.91B | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | $3.47B | Mar 1, 2023 |
| FY2021 | Dec 31, 2019 | $3.40B | Mar 1, 2022 |
| FY2020 | Dec 31, 2018 | $3.38B | Mar 10, 2021 |
| FY2019 | Dec 31, 2017 | $3.35B | Mar 13, 2020 |
| FY2018 | Aug 31, 2017 | $3.27B | Mar 15, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | ($815.20M) | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | ($737.30M) | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | ($569.20M) | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | ($557.30M) | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | ($502.70M) | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | ($431.80M) | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | ($315.70M) | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | ($247.00M) | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | ($41.32M) | Mar 15, 2019 |
| FY2016 | Dec 31, 2016 | ($311.35M) | Mar 10, 2017 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $239.90M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | $269.50M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | $195.90M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | $282.90M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | $389.90M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | $317.90M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | $92.70M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | $184.30M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | $174.91M | Mar 15, 2019 |
| FY2017 | Aug 31, 2017 | $214.21M | Mar 16, 2018 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.74B | Mar 2, 2026 |
| FY2024 | Dec 31, 2024 | $3.40B | Mar 7, 2025 |
| FY2023 | Dec 31, 2023 | $2.80B | Feb 26, 2024 |
| FY2022 | Dec 31, 2022 | $2.63B | Mar 1, 2023 |
| FY2021 | Dec 31, 2021 | $2.96B | Mar 1, 2022 |
| FY2020 | Dec 31, 2020 | $2.88B | Mar 10, 2021 |
| FY2019 | Dec 31, 2019 | $2.60B | Mar 13, 2020 |
| FY2018 | Dec 31, 2018 | $2.33B | Mar 15, 2019 |
| FY2017 | Dec 31, 2017 | $2.19B | Mar 16, 2018 |
| FY2016 | Dec 31, 2016 | $1.47B | Mar 10, 2017 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | (3) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 13, 2020 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 0 | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | (1) | Mar 2, 2026 |
| FY2025 | Dec 31, 2023 | 0 | Mar 2, 2026 |
| FY2024 | Dec 31, 2022 | 0 | Mar 7, 2025 |
| FY2023 | Dec 31, 2021 | (1) | Feb 26, 2024 |
| FY2022 | Dec 31, 2020 | (3) | Mar 1, 2023 |
| FY2019 | Dec 31, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Sep 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Jun 30, 2019 | 0 | Mar 13, 2020 |
| FY2019 | Mar 31, 2019 | 0 | Mar 13, 2020 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 129.32M | Mar 2, 2026 |
| FY2025 | Dec 31, 2024 | 127.11M | Mar 2, 2026 |
| FY2024 | Dec 31, 2023 | 126.59M | Mar 7, 2025 |
| FY2023 | Dec 31, 2022 | 125.96M | Feb 26, 2024 |
| FY2022 | Dec 31, 2021 | 89.33M | Mar 1, 2023 |
| FY2021 | Dec 31, 2020 | 50.46M | Mar 1, 2022 |
| FY2020 | Dec 31, 2019 | 49.30M | Mar 10, 2021 |
| FY2019 | Dec 31, 2018 | 48.87M | Mar 13, 2020 |
| FY2018 | Dec 31, 2017 | 48.69M | Mar 15, 2019 |
| FY2016 | Dec 31, 2016 | 48.49M | Mar 10, 2017 |